Alk-Abello As B Shs New (AKBLF) Q2 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Alk-abello A/s Class B.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:05.043 Hello everyone and welcome to this presentation of ALK's Q2 results and the 00:00:05.043 -- 00:00:08.111 revised full year outlook. Thank you all for joining us. 00:00:08.111 -- 00:00:13.109 Let's turn to slide number two with an intro to the agenda and the speakers. 00:00:13.109 -- 00:00:18.095 My name is Per Plotnikoff, I'm Head of Investor Relations and with me today are CEO Peter 00:00:18.095 -- 00:00:21.558 Helling and CFO Claus Steensen-Sølje. 00:00:21.558 -- 00:00:26.143 We'll first be sharing a couple of highlights from Q2, followed by a closer look at market 00:00:26.143 -- 00:00:29.067 and product trends, as well as half-year financials. 00:00:29.067 -- 00:00:34.152 We will then provide an update on recent progresses and on the pediatric agenda, our 00:00:34.152 -- 00:00:39.403 NEFI partnership, and other strategic priorities before we present the updated full year 00:00:39.403 -- 00:00:43.993 outlook. As usual, we will end the presentation with a Q&A session. 00:00:43.993 -- 00:00:47.862 To get started, I'll hand over to Peter for slide three for the highlights. 00:00:47.862 -- 00:00:49.829 Please go ahead, Peter. 00:00:49.829 -- 00:00:54.374 Thank you, Per, and thank you all for joining this call. 00:00:54.374 -- 00:00:58.900 Commercial execution of the key strategic initiatives, including the children launches, 00:00:58.900 -- 00:01:01.844 was on top of our agenda in Q2. 00:01:01.844 -- 00:01:06.890 These initiatives started contributing to sales growth in Q2, although they are 00:01:06.890 -- 00:01:09.753 still all in early stage. 00:01:09.753 -- 00:01:13.998 The initiatives have come off to a good start, and this bodes well for ALK's ability 00:01:13.998 -- 00:01:17.943 to deliver sustained profitable growth going fo...